Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Cogent Biosciences (COGT) Other Operating Expenses (2020)

Cogent Biosciences (COGT) has 1 years of Other Operating Expenses data on record, last reported at $46.9 million in Q3 2020.

  • For Q3 2020, Other Operating Expenses changed N/A year-over-year to $46.9 million; the TTM value through Jun 2021 reached $46.9 million, changed N/A, while the annual FY2020 figure was $46.9 million, N/A changed from the prior year.
  • Other Operating Expenses reached $46.9 million in Q3 2020 per COGT's latest filing.
  • Across five years, Other Operating Expenses topped out at $46.9 million in Q3 2020 and bottomed at $46.9 million in Q3 2020.